Efficacy and Safety Study of Tolvaptan to Treat Patients With Cardiac Edema
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 244 participants.
Also called NCT01651156
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 244 participants
- Registry
-
NCT01651156
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT01651156. Randomized; quadruple masking; primary purpose treatment. Start 2012-07 (registry gives no type); primary completion 2013-07 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety Study of Tolvaptan to Treat Patients With Cardiac Edema
- Condition
- Cardiac Edema
- Intervention (Drug)
- Tolvaptan
- Intervention (Drug)
- Placebo
- Lead sponsor
- Otsuka Beijing Research Institute
Record details
- Record id
cardio:ct-nct01651156- Content hash
244d7c17bac0ca5f0b7b7b3d974944432b3c8ed92d42e420e0dd19fbcd55ac22